期刊文献+

人类自然杀伤细胞活化性配体ULBPs的表达与调控

Expression and regulation of ULBPs,a human active ligand of NKG2D receptor
下载PDF
导出
摘要 人类自然杀伤细胞活化性配体UL16结合蛋白(UL16-binding proteins,ULBPs)家族至少由6个成员组成,其中ULBP1、ULBP2、ULBP3(ULl6-binding protein 1-3)分子含有α1和α2结构域,通过糖基磷脂酰肌醇(giycosylphosphatidylinositol,GPI)与细胞膜相连。ULBP4(UL16-binding protein 4)分子含有跨膜和胞质结构域。正常组织中广泛表达ULBPs。T淋巴细胞瘤、结肠癌、卵巢癌等肿瘤细胞表面也有ULBPs的高表达。化学药物、细胞因子、细菌和病毒感染等众多因素都可以调控ULBPs的表达,其中紫外线辐射、化疗药物等诱发的DNA损伤反应可以活化3-磷脂酰肌醇激酶家族类成员(ataxia-telangiecta- sia mutated,ATM)或(ataxia-telangiectasia and Rad3-related,ATR)激酶,进一步活化下游的Chk1、Chk2节点激酶和其他的凋亡相关分子,从而诱导ULBPs的表达,引起肿瘤细胞的生长周期停滞,诱导细胞凋亡,发挥抗肿瘤作用。另外,ULBP1启动子中CRE1位点活化也是上调ULBP1转录和表达的关键因素。对ULBPs表达与调控因素的深入探讨将为阐明肿瘤逃逸机制、寻求抗肿瘤有效药物提供新的作用靶点和思路。
作者 商平平 张彩
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 2007年第5期493-496,共4页 Chinese Journal of Cancer Biotherapy
基金 国家自然科学基金(No.30371302 30471527) 山东省优秀中青年科学家科研奖励基金(No.2005BS03015) 中国博士后基金(No.20060390309) 山东省博士后基金(No.200603071) Supported by the National Natural Science Foundation of China(No.30371302 30471527) the Distinguished Young Scientists Foundation of Shandong Province(No.2005BS03015) the National Postdoctoral Research Foundation of China(No.20060390309) the Postdoctoral Research Foundatioa of Shandong Province(No.200603071)
  • 相关文献

参考文献29

  • 1Smyth MJ, Swann J, Cretney E, et al. NKG2D function protects the host from tumor initiation [ J ]. J Exp Med, 2005, 202 (5) : 583-588.
  • 2Radaev S, Kattah M, Zou Z, et al.Making sense of the diverse ligand recognition by NKG2D[ J ]. J Immunol. 2002. 169 ( 11 ) : 6279-6285.
  • 3Vivier E, Tomasello E, Paul P,et al. Lymphocyte activation via NKG2D: towards a new paradigm in immune recognition [ J ] ? Curr Opin Immunol, 2002, 14(3) : 306-311.
  • 4Sutherland CL, Chalupny NJ, Schooley K, et al. UL16-binding proteins, novel MHC class 1-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells[ J ]. J Immunol, 2002, 168(2) : 671-679.
  • 5Eleme K, Taner SB, Onfelt B, et al. Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2D[J]. J Exp Med, 2004, 199(7) : 1005-1010.
  • 6Maghazaehi AA. Insights into seven and single transmembranespanning domain receptors and their signaling pathways in human natural killer cells[J]. Pharmacol Rev, 2005, 57(3): 339-357.
  • 7Long EO, Rajagopalan S. Stress signals activate natural killer cells [J]. J Exp Med, 2002, 196(11 ): 1399-1402.
  • 8Bahram S, Inoko H, Shiina T, et al. MIC and other NKG2D ligands: from none to too many[J]. Curr Opin Immunol, 2005, 17( 5 ) : 505-509.
  • 9Takaki R, Hayakawa Y, Nelson A, et al. IL-21 enhances tumor rejection through a NKG2D-dependent mechanism [ J]. J Immunol, 2005, 175(4) : 2167-2173.
  • 10Bui JD, Carayannopoulos LN, Lanier LL, et al. IFN-dependent down-regulation of the NKG2D ligand H60 on tumors[ J]. J Immunol, 2006, 176(2) : 905-1013.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部